Fund Holdings — Euclidean Capital LLC

Total Portfolio Value:
$305.72M
Total Bought:
$23.86M
Total Sold:
$802.6K
Net Transaction:
+$23.06M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Vanguard Intl Equity Index FALLWRLD EX US1,991,8842,142,684+150,800$120.83M$144.03M47.11%+$23.20M
Ishares TrMSCI INDIA ETF
MSCI INDIA ETF
2,425,1442,425,1440$124.85M$135.03M44.17%+$10.19M
ORIC Pharmaceuticals, Inc.(ORIC)989,410989,4100$5.52M$10.04M3.28%+$4.52M
Foghorn Therapeutics Inc.(FHTX)1,573,7611,573,7610$5.74M$7.40M2.42%+$1.65M
PMV Pharmaceuticals, Inc.(PMVP)2,627,6432,627,6430$2.86M$2.79M0.91%-$78.8K
State Street SPDR S&P 500 ETF TrustTR UNIT(SPY)4,1044,1040$2.30M$2.54M0.83%+$239.9K
Alector Inc1,307,8581,307,8580$1.61M$1.83M0.60%+$222.3K
Surrozen, Inc.(SRZN)87,69687,6960$1.02M$784.0K0.26%-$238.5K
Rapt Therapeutics Inc082,234+82,234$0$657.9K0.22%+$657.9K
Tenaya Therapeutics, Inc.(TNYA)1,015,7051,015,7050$579.1K$620.8K0.20%+$41.7K
Surrozen, Inc.W EXP 08 01 203(SRZN)170,833170,8330$5.1K$3.1K0.00%-$2.0K
Rapt Therapeutics Inc657,8990-657,899$802.6K$0—-$802.6K
Page 1 of 1
Euclidean Capital LLC — 13F Holdings — Q2 2025 | TickerTrail